Albumin-PRF in Sinus Lift With Implants: 2-Year Study

Mansoura University32 enrolled

Overview

thirty-two implants will be inserted in patients seeking implantation of their lost posterior maxillary teeth (premolar and molars) with limited bone height below the floor of the maxillary sinus, secondary to sinus pneumatization. The patients will be selected from those attending the outpatient clinic of the Oral \& Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Sinus Lift Augmentation

Interventions

lateral sinus lift with using allograft and pericardium membranePROCEDURE

sinus floor elevation with placing allograft and collagen membrane

lateral sinus lift with using exteneded platelet rich fibrinPROCEDURE

sinus floor elevation with placing extended-PRF

Eligibility

Sex: ALLMin age: 20 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patent ostium of maxillary sinus. * Patient with missing one or more posterior maxillary teeth. * Residual bone height of 3-6 mm, measured from the crest of alveolar ridge to the floor of the maxillary sinus at the planned implant site. * A ridge width at the site of implantation of \<5mm. * Platelets of normal range. * Good oral hygiene. * Patients in the age frame between 20 years and 60 years old. * No gender preface in selection of the patients. * A minimum crown height space of 8 mm. Exclusion Criteria: * Active sinusitis, cyst, tumors or root tips at the planned surgical site. * Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders. * Heavy smoking and alcoholism. * Parafunctional habits such as bruxism and clenching. * Signs of acute infection or pus discharge. * Disturbed occlusion.

Locations (1)

Mansoura University

Al Mansurah, Egypt

Outcomes

Primary Outcomes

1. implant stability

the stability of the implants will be evaluated by RFA with the Osstell Mentor device.

Time frame: 12 months

2. Vertical bone height

vertical bone height will be measured as the distance from the alveolar crest to the new sinus floor at the middle of the implant

Time frame: 24 Months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.